Document › Details
Waters Corporation. (7/25/05). "Press Release: Acquity Ultra Performance LC™ System Wins R&D 100 Award. Most Prestigious Honor in Applied Research". Milford, MA.
|Product||ACQUITY UPLC (Ultra Performance LC™) system|
For the third time in two years, the ACQUITY Ultra Performance LC (UPLC™) System is cited in an award for its innovation. The R&D 100 Award singles out the top 100 most technologically significant innovations known to industry, government, and academia.
According to Tim Studt, editor-in-chief of R&D Magazine, sponsors of this award, " Judges look for significant technological improvements - not incremental - and the 'Wow' factor that makes a product unusual, more interesting or clearly superior to what's currently available."
Judges are recruited from a pool of professional consultants, university faculty and industrial researchers. They recognized the ACQUITY UPLC™ System for achieving new levels in performance and efficiency.
Art Caputo, President, Waters Division, states, "Winning this award validates Waters' leadership position as an innovator in analytical instrumentation, software, chemistry and support in terms of changing the way scientists work. This single achievement took more than 72 inventors and principal developers along with a support team encompassing all areas from R&D to manufacturing."
The ACQUITY UPLC System significantly speeds the analysis of compounds in thousands of routine samples or detects compounds often missed in complex samples using conventional high performance liquid chromatography methods . It is already helping scientists fill the pipeline early with promising drug candidates and increasing R&D productivity at pharmaceutical and industrial organizations worldwide. The ACQUITY UPLC System is also used to confirm toxin levels (e.g. perchlorate, a known thyroid inhibitor) in drinking water, contaminants and banned substances (e.g. Sudan dyes, veterinary drugs and pesticide residues) in the food supply as well as to confirm levels of routine compounds such as caffeine in soft drinks.
Based on novel, sub two-micron patented particle technology , the ACQUITY UPLC System takes full advantage of the separation speed and efficiency these unique column packings provide. Adapting traditional systems to accommodate these columns at high speed was not an option. So the Waters development team broke new ground and designed a holistic system including instrumentation, software, chemistry and support -- without compromising either speed or efficiency.
This is the third honor of note given to the ACQUITY UPLC System, which also received the 2004 Pittcon Editors' Gold Award for Best New Product . ACQUITY UPLC technology was also the major reason cited by leading industry analyst firm Frost & Sullivan when it presented Waters with its 2005 Leading Analytical Instrumentation Company of the Year Award. Waters has also been the recipient of the R&D 100 Award before - most recently in 2000 for its XTerra® reversed-phase HPLC columns and in 1999 for its Oasis® HLB 96-well Extraction Plate.
R&D Magazine will profile the winners and their products in its September issue. The award ceremony will take place on October 20 th at Chicago's Navy Pier in Illinois.
Proven Applications and Accolades
Dr. Anton D. Jerkovich, from Novartis Pharmaceuticals Corporation believes "ACQUITY UPLC (System) will become the option of choice for the development of fast LC methods in pharmaceutical development in the near future." And according to Dr. Iain Beattie, at AstraZeneca's Physical & Metabolic Science facility, "(ACQUITY) UPLC-MS does offer significant gains over the capillary LC-MS for metabolite identification." And finally, Dr. Kenneth R. Wehmeyer from Proctor & Gamble Pharmaceuticals attests, "The ACQUITY UPLC System was shown to provide accurate and reproducible results for rapid isocratic and gradient analysis of drug molecules in dose formulations."For more information about these applications, please visit www.waters.com/acquity
About the R&D 100 Awards
The R&D 100 Award competition, now in its 43rd year, is open to the world's corporate, independent and university researchers and recognizes the year's 100 most technologically significant products and processes. To qualify, winning products or processes must have been available for sale or licensing during the calendar year preceding the judging. Winners are chosen by an independent panel of 70 experts.
The R&D 100 Awards were established in 1963 to identify the 100 most technologically significant new products in the marketplace in that year. Over the years, the R&D 100 Awards have recognized winning products with such household names as Polacolor film (1963), the flashcube (1965), the automated teller machine (1973), the fax machine (1975), the liquid crystal display (1980), the printer (1986), the Kodak Photo CD (1991), the Nicoderm antismoking patch (1992), Taxol anticancer drug (1993), lab on a chip (1996), and HDTV (1998).
About Waters Corporation
Waters Corporation holds worldwide leading positions in three complementary analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis. These market segments account for $4.5 - $5.0 billion of the overall $20+ billion analytical instrumentation market.
Waters, Oasis and XTerra are registered trademarks and ACQUITY Ultra Performance LC, ACQUITY UPLC and UPLC are trademarks of Waters Corporation.
Certain statements contained herein are forward looking. Many factors could cause actual results to differ from these statements, including delays in product introductions, loss of market share through competition, introduction of competing products by other companies, pressures on prices from competitors and/or customers, regulatory obstacles to new product introductions, lack of acceptance of new products, changes in the healthcare market and the pharmaceutical industry, changes in distribution of the Company's products, and foreign exchange fluctuations. Such factors are discussed in detail in the Company's filings with the Securities and Exchange Commission and, in particular, the Company's Annual Report on Form 10-K for the year ended December 31, 2004.
Record changed: 2016-03-19
More documents for Waters (Group)
-  Waters Corporation. (1/4/17). "Press Release: Waters CE-Marks In Vitro Diagnostic MassTrak Vitamin D Solution". Milford, MA....
-  Waters Corporation. (1/3/17). "Press Release: Waters Corporation Presentation at the 35th Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live". Milford, MA....
-  Waters Corporation. (12/29/16). "Press Release: Waters Corporation Presentation at the Goldman Sachs Healthcare CEOs Unscripted Conference to Be Audio Webcast Live". Milford, MA....
-  Waters Corporation. (12/19/16). "Press Release: Waters New Preparative SFC Columns Designed to Aid Purification Scale-Up Methods". Milford, MA....
-  Waters Corporation. (12/8/16). "Press Release: Waters Corporation Announces Sherry Buck as Chief Financial Officer". Milford, MA....
-  Waters Corporation. (11/30/16). "Press Release: International Phenome Centre Network Launches with Waters as a Founding Partner". Milford, MA....
-  Waters Corporation. (11/10/16). "Press Release: Waters Expands Cortecs Analytical Column Portfolio". Milford, MA....
-  Waters Corporation. (11/1/16). "Press Release: Vicam Now Offers a Single Extraction Test for Aflatoxins and Fumonisins in Corn and Grain". Milford, MA....
-  Waters Corporation. (11/1/16). "Press Release: Waters and Sotax Group Sign Co-Marketing and Re-Seller Agreement". Milford, MA....
-  Waters Corporation. (10/25/16). "Press Release: Waters Reports Third Quarter 2016 Financial Results". Milford, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]